Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Combined estrogen replacement therapy on metabolic control in postmenopausal women with diabetes mellitus.

Xu Y, Lin J, Wang S, Xiong J, Zhu Q.

Kaohsiung J Med Sci. 2014 Jul;30(7):350-61. doi: 10.1016/j.kjms.2014.03.002. Epub 2014 Apr 18.

PMID:
24924841
[PubMed - in process]
2.

The effects of hormone replacement therapy on plasma lipids in type II diabetes.

Manwaring P, Morfis L, Diamond T, Howes LG.

Maturitas. 2000 Mar 31;34(3):239-47.

PMID:
10717490
[PubMed - indexed for MEDLINE]
3.

Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.

Lopez LM, Grimes DA, Schulz KF.

Cochrane Database Syst Rev. 2012 Apr 18;4:CD006133. doi: 10.1002/14651858.CD006133.pub4. Review. Update in: Cochrane Database Syst Rev. 2014;4:CD006133.

PMID:
22513937
[PubMed - indexed for MEDLINE]
4.

Hormone replacement therapy for cognitive function in postmenopausal women.

Lethaby A, Hogervorst E, Richards M, Yesufu A, Yaffe K.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD003122. doi: 10.1002/14651858.CD003122.pub2. Review.

PMID:
18254016
[PubMed - indexed for MEDLINE]
5.

Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.

Lopez LM, Grimes DA, Schulz KF.

Cochrane Database Syst Rev. 2014 Apr 30;4:CD006133.

PMID:
24788670
[PubMed - in process]
6.

Long term hormone therapy for perimenopausal and postmenopausal women.

Marjoribanks J, Farquhar C, Roberts H, Lethaby A.

Cochrane Database Syst Rev. 2012 Jul 11;7:CD004143. doi: 10.1002/14651858.CD004143.pub4. Review.

PMID:
22786488
[PubMed - indexed for MEDLINE]
7.

Prior to use of estrogen replacement therapy, are users healthier than nonusers?

Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P.

Am J Epidemiol. 1996 May 15;143(10):971-8.

PMID:
8629615
[PubMed - indexed for MEDLINE]
Free Article
8.

Hormone replacement therapy in women with breast cancer. Do the risks outweigh the benefits?

Roy JA, Sawka CA, Pritchard KI.

J Clin Oncol. 1996 Mar;14(3):997-1006. Review.

PMID:
8622051
[PubMed - indexed for MEDLINE]
Free Article
9.

Hormone replacement therapy to maintain cognitive function in women with dementia.

Hogervorst E, Yaffe K, Richards M, Huppert F.

Cochrane Database Syst Rev. 2002;(3):CD003799. Review. Update in: Cochrane Database Syst Rev. 2009;(1):CD003799.

PMID:
12137718
[PubMed - indexed for MEDLINE]
10.

Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial.

Lacut K, Oger E, Abalain JH, Moineau MP, Mottier D; SARAH Investigators.

Atherosclerosis. 2004 May;174(1):173-80.

PMID:
15135267
[PubMed - indexed for MEDLINE]
11.

Estrogen replacement therapy and worsening of radiographic knee osteoarthritis: the Framingham Study.

Zhang Y, McAlindon TE, Hannan MT, Chaisson CE, Klein R, Wilson PW, Felson DT.

Arthritis Rheum. 1998 Oct;41(10):1867-73.

PMID:
9778229
[PubMed - indexed for MEDLINE]
12.

[Effect of hormone replacement therapy on blood serum lipids in postmenopausal women with type 2 diabetes].

Kozlov SG, Dotsenko IuV, Sankova AV, Liakishev AA, Tvorogova MG, Afanas'eva OI, Titov VN, PokrovskiÄ­ SN, Naumov VG.

Kardiologiia. 2002;42(7):47-52. Russian.

PMID:
12494113
[PubMed - indexed for MEDLINE]
13.

Type A behavior pattern, heart disease risk factors, and estrogen replacement therapy in postmenopausal women: the Rancho Bernardo Study.

Buller JC, Kritz-Silverstein D, Barrett-Connor E, Wingard D.

J Womens Health. 1998 Feb;7(1):49-56.

PMID:
9511132
[PubMed - indexed for MEDLINE]
14.

Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.

Vrablik M, Fait T, Kovar J, Poledne R, Ceska R.

Metabolism. 2008 Aug;57(8):1088-92. doi: 10.1016/j.metabol.2008.03.012.

PMID:
18640386
[PubMed - indexed for MEDLINE]
15.

Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2009;9(20):1-58. Epub 2009 Oct 1.

PMID:
23074525
[PubMed]
Free PMC Article
16.

Effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures.

Nguyen TV, Jones G, Sambrook PN, White CP, Kelly PJ, Eisman JA.

J Clin Endocrinol Metab. 1995 Sep;80(9):2709-14.

PMID:
7673413
[PubMed - indexed for MEDLINE]
17.

Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.

Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.

Climacteric. 2002 Dec;5(4):341-50.

PMID:
12626213
[PubMed - indexed for MEDLINE]
18.

Hormone therapy for sexual function in perimenopausal and postmenopausal women.

Nastri CO, Lara LA, Ferriani RA, Rosa-E-Silva AC, Figueiredo JB, Martins WP.

Cochrane Database Syst Rev. 2013 Jun 5;6:CD009672. doi: 10.1002/14651858.CD009672.pub2. Review.

PMID:
23737033
[PubMed - indexed for MEDLINE]
19.

The effects of exercise training on abdominal visceral fat, body composition, and indicators of the metabolic syndrome in postmenopausal women with and without estrogen replacement therapy: the HERITAGE family study.

Green JS, Stanforth PR, Rankinen T, Leon AS, Rao Dc Dc, Skinner JS, Bouchard C, Wilmore JH.

Metabolism. 2004 Sep;53(9):1192-6.

PMID:
15334383
[PubMed - indexed for MEDLINE]
20.

Short and long term effects of tibolone in postmenopausal women.

Formoso G, Perrone E, Maltoni S, Balduzzi S, D'Amico R, Bassi C, Basevi V, Marata AM, Magrini N, Maestri E.

Cochrane Database Syst Rev. 2012 Feb 15;2:CD008536. doi: 10.1002/14651858.CD008536.pub2. Review.

PMID:
22336846
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk